9:00 AM SIGN-IN • 9:30 AM - 11:00 AM

BANDOL 2 (NEW WYNN SPACE)

CE: The Dynamic Landscape of CLL and Its Effect on Specialty Pharmacy Practice

Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in adults, with more than 20,000 patients diagnosed annually in the United States. New and expanded approvals in the past 12 months are changing the treatment landscape and ultimately the outcomes of patients with CLL. Evidence for the use of oral monotherapy, oral combination therapies, and oral oncolytics in combination with chemoimmunotherapy is rapidly progressing. Specialty pharmacists are uniquely positioned to manage and counsel patients as well as to advise health care professionals about adverse effects and novel guideline-recommended targeted options. This session will highlight the latest information on therapeutic strategies for patients with CLL as well as the pharmacist’s role in developing patient-centered solutions, including coordination of care across practice settings, adherence and monitoring strategies, and patient self-care management.

Speakers

Allison Duffy

Kirollos Hanna

Asembia

200 Park Avenue, Suite 300 
Florham Park, NJ 07932

973.564.8004

asembia.com

info@asembiasummit.com

SIGN UP FOR SUMMIT UPDATES

Asembia's Specialty Pharmacy Summit is a PRIVATE EVENT. Asembia reserves the right to deny registration and refuse access at our absolute and sole discretion for any reason whatsoever.

© 2020 Asembia Specialty Pharmacy Summit, LLC. All rights reserved.

CONNECT WITH US

  • Asembia LinkedIn
  • Asembia Twitter
  • Asembia Instagram
  • Asembia Facebook
  • Asembia Videos
  • Asembia Photos
2021Summit_Logo_White.png